Pro Football weekly

Comment | Print |

Cushing denies taking banned substance

Related Stories

Titans make twin killing; sign OG Levitre, TE Walker

Posted March 12, 2013 @ 5:39 p.m.

Houston Texans: 2013 team needs

Posted March 08, 2013 @ 2:20 p.m.

Baker to lead Houston's Super Bowl bid

Posted Feb. 25, 2013 @ 3:35 p.m.

Freeney's exit latest example of Colts' sea change

Posted Feb. 16, 2013 @ 3:24 p.m.

Texans want Barwin back despite disappointing 2012

Posted Feb. 07, 2013 @ 2:55 p.m.

Texans RB Foster has not talked surgery

Posted Feb. 01, 2013 @ 1:20 p.m.

Foster: Don't expect 100 percent play at Pro Bowl

Posted Jan. 25, 2013 @ 9:29 p.m.

Texans won't rule out drafting QB

Posted Jan. 16, 2013 @ 2:53 p.m.

Watt named PFW/PFWA Defensive Player of the Year

Posted Jan. 16, 2013 @ 11:20 a.m.

Texans WR Posey tears Achilles tendon

Posted Jan. 13, 2013 @ 9:29 p.m.
Posted May 13, 2010 @ 3:06 p.m. ET
By PFW staff

Texans SLB Brian Cushing, facing a four-game suspension for violating the NFL's policy on anabolic steroids and related substances, said Thursday said he did not "inject or ingest" any illegal substances.

"I would never do anything to cheat this game," Cushing said Thursday, according to the club's official Twitter feed.

Cushing tested positive for hCG, or human chorionic gonadotropin, a substance banned by the NFL which is sometimes used by steroid users who want to restart testosterone production. It is also used by women trying to become pregnant. According to The Houston Chronicle, Cushing said doctors told him that the substance can be introduced into the system by injection or can signal the presence of a tumor.  

"I was tested in September, and I found out in October I had tested positive," he said, according to the Chronicle. "I played the rest of the season thinking I had tumors."

According to the Chronicle, Cushing said he would seek "medical help to find out what it happened and to keep it from happening again."


For the most authoritative NFL draft news and free-agency analysis, visit


Comments ()